Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Psychoneuroendocrinology|April 1, 2016
Oxytocin's effect on resting-state functional connectivity varies by age and sexNatalie C Ebner, Huaihou Chen, Eric Porges, et al.
Clinical Case Reports|May 24, 2021
A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depressionTerry Schwartz, Mary Ellen Trunko, David Feifel, et al.
Frontiers in Human Neuroscience|September 7, 2013
Oxytocin and socioemotional aging: Current knowledge and future trendsNatalie C Ebner, Gabriela M Maura, Kai Macdonald, et al.
Psychopharmacology|June 24, 2008
The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit toleranceDavid Feifel, Gilia Melendez, Rachel J Murray, et al.
Frontiers in Psychology|February 7, 2015
Hormones as "difference makers" in cognitive and socioemotional aging processesNatalie C Ebner, Hayley Kamin, Vanessa Diaz, et al.
Frontiers in Psychology|July 11, 2022
Age-Related Differences in Amygdala Activation Associated With Face Trustworthiness but No Evidence of Oxytocin ModulationTian Lin, Didem Pehlivanoglu, Maryam Ziaei, et al.
Neurobiology of Aging|March 15, 2019
Oxytocin alters patterns of brain activity and amygdalar connectivity by age during dynamic facial emotion identificationMarilyn Horta, Maryam Ziaei, Tian Lin, et al.
Brain Stimulation|June 16, 2021
Seizure risk with repetitive TMS: Survey results from over a half-million treatment sessionsJoseph J Taylor, Noam G Newberger, Adam P Stern, et al.
The Journal of Clinical Psychiatry|April 21, 2004
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepamGlenn W Currier, James C-Y Chou, David Feifel, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2004
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorderSharon Wigal, James M Swanson, David Feifel, et al.
Pageof 11